Property	Value
Status
Version
Ad File
Disable Ads Flag
Environment
Moat Init
Moat Ready
Contextual Ready
Contextual URL
Contextual Initial Segments
Contextual Used Segments
AdUnit
SubAdUnit
Custom Targeting
Ad Events
Invalid Ad Sizes

Deborah J. Wexler MD, MSc Associate Editor

Silvio E. Inzucchi MD Editor-in-Chief

See All Experts

featured

Published in Diabetes

Journal Scan / Research · March 11, 2024

Effects of Exogenous GIP and GLP-2 on Bone Turnover in Individuals With Type 2 Diabetes

The Journal of Clinical Endocrinology and Metabolism

Save Recommend

Sign in to PracticeUpdate

Only registered members have full access to PracticeUpdate content.

Not a member?

Join for free

Disclosure statements are available on the authors' profiles:

Matthew Gilbert DO, MPH

Carolina Gonzalez-Lopez MD

The Journal of Clinical Endocrinology and Metabolism

Effects of exogenous GIP and GLP-2 on bone turnover in individuals with type 2 diabetes

J. Clin. Endocrinol. Metab. 2024 Jan 13;[EPub Ahead of Print], K Skov-Jeppesen, CB Christiansen, LS Hansen, JA Windeløv, N Hedbäck, LS Gasbjerg, M Hindsø, MS Svane, S Madsbad, JJ Holst, MM Rosenkilde, B Hartmann

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Effects of Exogenous GIP and GLP-2 on Bone Turnover in Individuals With Type 2 Diabetes

Additional Info

Effects of exogenous GIP and GLP-2 on bone turnover in individuals with type 2 diabetes

Further Reading

Weight Maintenance Using Cost-Effective Antiobesity Medications After 1 Year of GLP-1 Receptor Agonist Therapy

Trends in the Incidence of Young Adult–Onset Diabetes by Diabetes Type

Prognosis of Severe Hypoglycaemia and Diabetic Ketoacidosis in Adults Presenting to an Emergency Department

Perinatal Outcomes in Patients With Early vs Late Gestational Diabetes Mellitus Treated Between 24 and 28 Weeks of Gestation

Pathophysiology and Treatment of Prediabetes and Type 2 Diabetes in Youth

Relationship Between Early-Pregnancy Glycemia and Adverse Outcomes

Effect of Dapagliflozin on Renal Haemodynamics in Patients With Type 2 Diabetes and Glomerular Hyperfiltration

Effects of GLP-1 Receptor Agonists on Kidney and Cardiovascular Disease Outcomes

Predictors of Liver Fibrosis Progression in Patients With Type 2 Diabetes Mellitus and MASLD

Effect of Combined Use of SGLT2 Inhibitors and Pioglitazone on the Risk of MASH in Individuals With Type 2 Diabetes

Cumulative Impact of Type 2 Diabetes and Obstructive Sleep Apnoea on Cardiovascular, Liver, Diabetes-Related, and Cancer Outcomes

Recently Updated